https://www.indianpharmapost.com/teva-wins-investment-grade-upgrade-from-moodys-213552026-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/stempeutics-secures-us-patent-for-stem-cell-based-osteoarthritis-treatment-213562026-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/nephroplus-q1fy27-revenue-rises-237-to-rs-2818-crore-213572026-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-agarwals-health-care-sees-rs-2000-crore-block-deal-as-tpg-sell-126-stake-213582026-08-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/sparc-reports-rs-2078-crore-loss-in-q1fy27-213592026-08-13T00:00:00+05:30always0.9